AIMarketStock 0 FeesIPO Earn
06160 logo

06160 (06160)

Company Profile

Contact Information

Market News

  • BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries2026-08-18T10:00
  • BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration2026-08-10T10:00
  • BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates2026-08-05T10:00
  • BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 52026-07-17T10:01

Financial Highlights

loading